The authors have previously shown that Bob1 is required for germinal center formation and B cell isotype switching, a defect that they previously ascribed to B cells. To look at the role of Bob1 in TFH cells, they immunized mice and analyzed the expression of cell surface molecules thought to characterize TFH cells CXCR5, along with either PD1 (the standard), ICOS, and BTLA. The latter two are really not TFH specific. A better indicator is BCL6, and yet the authors do not show us Bcl6 expression until Figure 6 , and then it is not a bivariate plot with CXCR5. In addition, the number of cells is not shown, only the percentages, and this definitely needs to be corrected. Finally, if the defect was only in B cells, there would still be a dramatic decrease in TFH cells (Deenick et al., Immunity, 2010) . In Figure 4 the authors show that indeed, there is a T cell intrinsic effect of the BOB1 knockout, but they still do not show cell numbers, only percentages, and they use ICOS and BTLA expression to enumerate the CXCR5+ TFH cells. No PD1, and still no BCL6. They probably have the right answer, but from these data it is not entirely clear.
I don't think reviewers should edit manuscripts, but in this case figures 1-3 are not really revealing. The interesting effect that is the focus of this paper is shown in Figure 4 using mixed bone marrow chimeras.
Having shown that there is a T cell intrinsic effect, they revert to using germline knockout mice, which are complicated by an absence of competent B cell antigen presenting cells. They show reduced IL21R and IL6R expression, but then how much of that failure to express cytokine receptors is due to reduced B cell antigen presentation?
The same results occur for Bcl6 expression in Figure 6 . A smaller proportion of knockout TFH (gated on CXCR5 and ICOS) express Bcl6 at high levels indicative GC-TFH cells. Again there are no total cell numbers, but the main problem is distinguishing the cell intrinsic inability to differentiate into TFH cells that enter germinal centers and express high BCL6 from a defect in antigen presentation by the defective B cells. This is the main concern I have.
The enhancer work looks very nice, except the ChIP data were carried out on in vitro generated TFH cells. As far as I know such in vitro conditions don't really recapitulate TFH cells. They didn't show the phenotype of these cells, and I would imagine there are few if any CXCR5+BCL6+ cells in these cultures.
There is quite a bit of high quality work in this report, and they may have the right answer. Still, the comparisons of germline ko and wt mice are too complicated. The use of in vitro differentiation is not appropriate.
Referee #2:
The authors study the function of the transcriptional regulator Bob-1 in differentiation of follicular helper CD4+ T cells (Tfh). They find that ablation of the gene encoding Bob-1 (Pou2af1) in mice leads to substantial defects in Tfh generation, in multiple tissues, and that the Tfh-like cells that do develop display unusual features, such as low expression of IL-21R, IL-6R and Bcl-6. Importantly, the authors use mixed bone marrow chimeras (with stem cells from Pou2af1 WT and KO donors) to show that key elements of the phenotype are cell-autonomous. Mechanistically, the authors show that Bob-1 enhances the activity of Oct2 in induction of expression from Btla and Bcl6 regulatory elements, and that activation of Bcl6 promoter elements required putative Oct-binding sites. Together, these data suggest that, in cooperation with Oct factors, Bob-1 plays a critical, cell autonomous role in Tfh differentiation, potentially due to the ability of Bob-1 to enhance expression of Btla and Bcl-6 (and potentially the genes encoding components of the IL-6R and IL-21R).
These are well-reasoned experiments, with thoughtful controls, and the data are mostly compelling. There are a few concerns, however, outlined below. 1) As the authors mention, a report from Corcoran's group (Karnowski et al. 2012 ) appears to contradict the conclusion that Tfh differentiation is dependent on cell autonomous expression of Bob-1 by T cells. The explanation offered -that Tfh differentiation in the context of influenza infection (the system used by Karnowski et al.) involves stronger innate cues -may be valid, but raises the important question of whether the immune response is better modeled by use of a live pathogen or sheep red blood cells. (The authors do use another immunogen -OVA with Alum -in their studies using OT-II T cells, but this is another relatively weak and non-infectious model system). It would be useful for the authors to use an infectious disease model to see whether they can extend their data to a more physiological system.
2) Given the fact the Pou2af1-/-animals display numerous defects in B cell generation, and a cellautonomous defect in GC-B cell differentiation (Fig 4 and Karnowski et al. 2012) , it is somewhat surprising that there appears to be little difference in the extent of Tfh differentiation in the "intact" Pou2af1-/-animals compared to mixed bone marrow chimeras (e.g. compare Figures 4C and 2B ). If anything, the extent of the defective Tfh generation seems to be magnified in Pou2af1-/-CD4+ T cells from the mixed chimeras, whereas one might expect the presence of WT B cells in that system would partially restore the KO T cell response. Do the authors have an explanation for these findings?
3) Members of this group have shown previously that Bob-1 induces Ifng transcription, and this fact is used as a positive control in Figs 8, 9 . It might follow that (among their other defects), the Tfhphenotype CD4+ T cells that differentiate from Pou2af1-/-precursors would display a reduced capacity to produce IFN-γ. Is this in fact the case, and have the authors tested this (and other cytokines, such as IL-21) produced by this KO population?
1st Revision -authors' response 18 November 2015 Referee #1:
This is an interesting study on the role of the Pou2af1 gene encoding BOB1 in the production of TFH cells. I think there are issues that would prevent publication in the present form.
Response 1:
We would like to thank the reviewer for the generally positive comments and agree, that more data on CXCR5 + PD1 + Tfh cells are desirable in this study. PD1 -in combination with CXCR5 -is certainly the most important surrogate marker for the identification of germinal center Tfh cells. However, Tfh cells are a rather heterogeneous population of CD4 + CXCR5 + Bcl6 + T cells that also express high levels of ICOS and, in part, BTLA. We think that the analysis of CD4 + CXCR5 + Tfh cells expressing different costimulatory molecules covers a wider range of follicular CD4 + T cells that differ with respect to their stage of differentiation and functional specialization. ICOS plays an important role for the correct localization of Tfh cells within secondary lymphoid organs by regulating Tfh homing molecules but it is also required for the maintenance of the phenotype of differentiated Tfh cells in the late GC reaction (Weber, et al., 2015) . Our data on the coexpression of ICOS, PD1 and BTLA on CD4 + CXCR5 + T cells ( Figure 2E ) suggests that ICOS identifies a broader spectrum of CXCR5-expressing CD4 + T cells than PD1, comprising the majority Figure 4C and for the adoptive transfer model to Figure 4D . The data show that the defect in the generation of PD1 + Tfh cells is comparable to the one observed for ICOS + Tfh cells. A comprehensive overview on the cell numbers in these experiments has been added to Figure EV1 . According to the suggestions by the reviewer we have also extended our analysis on Bcl6 expression in bone marrow chimeric mice. In addition to the data presented in Figure 6B , we set up novel experiments to visualize the differential expression levels of Bcl6 in Bob1-deficient and Bob1-sufficient Tfh cells defined by either ICOS ( Figure 6C ) or PD1 expression ( Figure EV2A ). We also added bivariate plots for Bcl6 and CXCR5 that illustrate the different capacity of these cells to develop into CXCR5 hi Bcl6 hi Tfh cells ( Figure 6D ) or PD1 hi CXCR5 hi Tfh cells (Fig EV2B) . Bob1-deficiency seems to have a similar impact on Bcl6 expression in ICOS + Tfh cells compared to PD1 + Tfh cells, suggesting that Bob1 does not specifically act in GC-Tfh cells but instead plays a more general role in Tfh cell development. In line with this hypothesis, Pou2af1 mRNA has been found upregulated in both early Tfh cells and GC Tfh cells by large-scale gene expression analysis (Choi, et al., 2015) . The purpose of Figures 2 and 3 is a broad view on the impact of Bob1 on Tfh cell development in a T cell-dependent immune response. Figure 2E illustrates the coexpression pattern of ICOS, PD1 and BTLA on CD4 + CXCR5 + T cells as all three markers have been used as surrogate markers for Tfh cells in the literature. Figure 2 shows the influence of Bob1 on Tfh cell development without distinguishing between T cell-intrinsic and secondary, B cell-dependent defects, which is the purpose of Figure 4 . We agree that the defects observed in Bob1-deficient B cells might severely affect the differentiation of Tfh cells as they rely on continuous antigen presentation by B cells (Deenick et al. 2010 ). In addition, Karnowski et al. (2012) reported that the B cell transcription factors Oct2 and Bob1 were required for B cell IL-6 production, which contributes to Tfh formation. The more pronounced defect in Pou2af1 -/-Tfh cell differentiation in germ line knockout mice compared to mixed bone marrow chimeras (see Figure 2 and Figure 4) suggests that both B cell and T cell-intrinsic defects contribute to the phenotype observed in Pou2af1 -/-mice.
Response 2:
It was a valuable suggestion to determine receptor expression in mixed bone marrow chimeras in the presence of competent antigen presenting B cells. As we observed no difference in the expression level of IL6Ra and IL21R for Pou2af1 +/+ and Pou2af1 -/-PD1 + or ICOS + expressing Tfh cells, we have replaced the data from germline knockout mice by the novel, more conclusive data sets obtained with mixed bone marrow chimeras.
Response 3:
We are aware that the availability of antigen presented by B cells and DCs is critical to the differentiation of Tfh cells (Deenick et al., 2010) . To separate a T cell intrinsic defect from possible defects in antigen presentation by Pou2af1 -/-B cells we generated Pou2af1 +/+ : Pou2af1 -/-mixed bone marrow chimeras and took advantage of the fact that Pou2af1 -/-bone marrow cells exhibit a defect in repopulating the bone marrow B cell compartment (Hess et al., 2001) . Consequently, the majority (>80%) of mature B220
+ B cells present in secondary lymphoid organs of our mixed bone marrow chimeras were Pou2af1 +/+ B cells and less than 20% Pou2af1 -/-B cells ( Figure 4A ). Figure 4 and 6 show conclusively a T cell intrinsic role for Bob1 in Tfh cell differentiation.
Response 4:
We agree with the reviewer that freshly isolated Tfh cells would be preferable over in vitro polarized cells. However, due to the low frequency of Pou2af1 -/-Tfh cells in either bone marrow chimeric mice (the preferred option) or Pou2af1 -/-mice and the reduced overall size of the CD4 + T cell compartment in the knockout animals we were not able to obtain a sufficient number of Tfh cells for ChIP analysis. The stimulation of naive CD62L + CD4 + T cells for 4 h was, however, sufficient to induce Bcl6 mRNA, levels of which were higher in Pou2af1 +/+ CD4 + T cells than in Pou2af1 -/-CD4 + T cells. We agree, that the text describing the ChiP experiment is not fully correct and therefore changed the passus "…we performed chromatin immunoprecipitation (ChIP) experiments on in vitro generated wild-type, heterozygous and Bob1-deficient Tfh cells." On page 12 to "…we performed chromatin immunoprecipitation (ChIP) experiments on naïve wild-type or heterozygous and Bob1-deficient CD4 + T cells that were maintained for four hours under Tfhinducing conditions (IL-21+IL-6) in vitro."
Referee #2:
Response 5:
We thank the reviewer for these positive overall comments on our study. The choice of model is a valid and important question. Our focus was more mechanistic as we were interested in the identification of target genes for Bob1 when we discovered that Pou2af1 -/-CD4 + T cells have an intrinsic defect in Tfh cell differentiation. In our view and according the actual literature in the field, sheep red blood cells and OVA are established and valid protein immunization strategies in modeling T cell-depending immune responses. A comparison of different model types was, however, beyond the scope of our project.
2) Given the fact the Pou2af1 -/-animals display numerous defects in B cell generation, and a cellautonomous defect in GC-B cell differentiation (Fig 4 and Karnowski et al. 2012) , it is somewhat surprising that there appears to be little difference in the extent of Tfh differentiation in the "intact" Pou2af1 -/-animals compared to mixed bone marrow chimeras (e.g. compare Figures 4C and 2B ). If anything, the extent of the defective Tfh generation seems to be magnified in Pou2af1 -/-CD4+ T cells from the mixed chimeras, whereas one might expect the presence of WT B cells in that system would partially restore the KO T cell response. Do the authors have an explanation for these findings?
Response 6:
The reduction in the frequencies of splenic Pou2af1 -/-Tfh cells was indeed strong in the bone marrow chimera experiment presented in in Figure 4C . The reductions observed in mesenteric lymph nodes and Peyer's Patches were, however, less pronounced than those observed in Pou2af1-deficient mice. With further experiments it became apparent that the defect in the spleen is less severe than the data set in the original figure suggested. We now present a larger data set (n=11) in the revised version of the manuscript and included -as suggested by reviewer #1 -data for PD1 + CXCR5 + Tfh cells. The figure clearly shows that the reduction in the frequency of Tfh cells is generally less severe in bone marrow chimeras then the defect observed in Pou2af1-deficient mice. It also shows that this defect is slightly more pronounced in ICOS + Tfh cells compared to PD1 + Tfh cells and also more pronounced in mesenteric lymph nodes and Peyer's patches compared to the spleen. The defect is, however, strongest for BTLA + Tfh cells, suggesting that Bob1 plays an important role in BTLA expression in Tfh cells. The presence of wild type antigen presenting B cells is most likely responsible for the partial recovery of Pou2af1 -/-Tfh cells in mixed bone marrow chimeras (see above, response 3 to reviewer #1).
3) Members of this group have shown previously that Bob-1 induces Ifn-g transcription, and this fact is used as a positive control in Figs 8, 9 . It might follow that (among their other defects), the Tfh-phenotype CD4+ T cells that differentiate from Pou2af1 -/-precursors would display a reduced capacity to produce IFN-γ. Is this in fact the case, and have the authors tested this (and other cytokines, such as IL-21) produced by this KO population?
Response 7:
We have analyzed the expression of IL-21 and IFN-g by CD4 cells from bone marrow chimeras. We did not get reliable results for IL-21 expression by flow cytometry analysis. For IFN-g we did not observe differences in the expression level for Pou2af1 -/-and Pou2af1 +/+ CD4 + T cells that were isolated from spleens of mixed bone marrow chimeras and stimulated with PMA/Ionomycin prior to flow cytometric analysis of IFN-g expression. 
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The sample size was typically calculated for the specific experiment and for an expected effect size by power analysis (see below). Calclations were performed using i. e. the software G*Power (http://www.gpower.hhu.de/)
For animal experiments, we routinely performed sample size estimates by power analysis as part of the experimental design. The number of animals required was calculated for pre--specified effect sizes (drawn from published studies or previous experiments on Tfh cells) with a type I error of 5% and a power of 95 %. Calculations were performed for nonparametric analyses (two--tailed) without assuming a normal distribution of the sample.
Criteria for animal exclusion from the sample size were pre--established (1) Failure of Reconstitution (animals would have been excluded prior to immunization and do not count for the actual group size) (2) Animals showing complications that are demonstrably not related to the intervention under study (3) Failure of the staining protocol, i.e. lack of specific signals in flow cytomety analysis The magnitude of the immune response did not constitute an exclusion criteria as we tested the hypothesis, that the magnitude of the response is influenced by the genotype under investigation NA; All animals in an experiment received the same treatment (see below)
NA; Treatment was not randomly allocated as there were no treatment options available within a given experiment. The aim of all animal experiments in this study was a comparison of the immune response/CD4+ T cell differentiation in wild type, heterozygous and gene--deficient animals or --in the case of mixed bone marrow chimeras --a direct comparison of CD4+ T cell differentiation for two genotypes in a single animal. Animals were grouped according to their genotype and all animals received the same treatment (immunization with either NP--KLH, sheep red blood cells or OVA, depending on the experiment). For the reason of sample size we did not assume a Gaussian distribution and applied the non--parametric Mann--Whitney Test (two--tailed) for all experiments (see materials an Methods "Statistical Analysis").
(1) Due to the sample size we did not assume a normal distribution. The analysis for normal distribution showed, however, that the large majority of groups that were assigned to statistical analyses (Figures 2--6 The spread of data within groups has been analyzed by calculating the standard deviation (and the variance) as sensitive measures and also by visualizing interquartile ranges as a resistant measure. We did not observe unexpected differences between the groups that are being statistically compared (see also below).
